相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer
Yu Liu et al.
CLINICAL IMMUNOLOGY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells
Lian Li et al.
IMMUNOLOGY LETTERS (2007)
DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors
Dae-Seog Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells
Graziella Bellone et al.
JOURNAL OF IMMUNOLOGY (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis
Jinah Jang et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Regulation of MHC class II gene expression by the class II transactivator
W Reith et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Enhanced production of IL-10 by dendritic cells deficient in CIITA
CSK Yee et al.
JOURNAL OF IMMUNOLOGY (2005)
MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells
S LeibundGut-Landmann et al.
NATURE IMMUNOLOGY (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Specificity and expression of CIITA, the master regulator of MHC class II genes
S LeibundGut-Landmann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs
T Kamio et al.
BLOOD (2003)
Regulation of class II MHC expression in APCs: Roles of types I, III, and IV class II transactivator
RK Pai et al.
JOURNAL OF IMMUNOLOGY (2002)
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
M Ratta et al.
BLOOD (2002)
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation
CC Sombroek et al.
JOURNAL OF IMMUNOLOGY (2002)
Genetic control of MHC class II expression
JPY Ting et al.
CELL (2002)
Haematopoietic cell-fate decisions, chromatin regulation and ikaros
K Georgopoulos
NATURE REVIEWS IMMUNOLOGY (2002)
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10
RD Brown et al.
BLOOD (2001)
The IL-7 receptor controls the accessibility of the TCRγ locus by Stat5 and histone acetylation
SK Ye et al.
IMMUNITY (2001)
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression
S Landmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Engagement of FcεRI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells
N Novak et al.
JOURNAL OF IMMUNOLOGY (2001)
Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity
K Nickerson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
DNA binding specificity of different STAT proteins -: Comparison of in vitro specificity with natural target sites
GB Ehret et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression
JM Waldburger et al.
IMMUNOLOGICAL REVIEWS (2000)
分享论文
